Portions of this exhibit marked as “[***]” have been excluded because they are both not material and would likely cause competitive harm to the registrant if publicly disclosed. AMENDMENT TO THE LICENSE AGREEMENT OF SEPTEMBER 20, 2013License Agreement • October 15th, 2020 • Tenax Therapeutics, Inc. • Services-commercial physical & biological research
This amendment agreement (hereinafter referred to as the “Amendment”) is made and executed as of this 9th day of October, 2020 (“Effective Date of Amendment”) by and between:
